These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 33042449)

  • 1. Long non-coding RNA ADAMTS9-AS1 exacerbates cell proliferation, migration, and invasion via triggering of the PI3K/AKT/mTOR pathway in hepatocellular carcinoma cells.
    Zhang Z; Li H; Hu Y; Wang F
    Am J Transl Res; 2020; 12(9):5696-5707. PubMed ID: 33042449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA ADAMTS9-AS2 inhibits liver cancer cell proliferation, migration and invasion.
    Li H; Huang H; Li S; Mei H; Cao T; Lu Q
    Exp Ther Med; 2021 Jun; 21(6):559. PubMed ID: 33850531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA DCST1-AS1 accelerates the proliferation, metastasis and autophagy of hepatocellular carcinoma cell by AKT/mTOR signaling pathways.
    Li J; Zhai DS; Huang Q; Chen HL; Zhang Z; Tan QF
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6091-6104. PubMed ID: 31364110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. lncRNA ADAMTS9-AS1 promotes bladder cancer cell invasion, migration, and inhibits apoptosis and autophagy through PI3K/AKT/mTOR signaling pathway.
    Yang G; Li Z; Dong L; Zhou F
    Int J Biochem Cell Biol; 2021 Nov; 140():106069. PubMed ID: 34428588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melittin inhibits the proliferation migration and invasion of HCC cells by regulating ADAMTS9-AS2 demethylation.
    Lv C; Chen J; Huang F; Fang F; Li B
    Toxicon; 2023 Jan; 222():106996. PubMed ID: 36535531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long Noncoding RNA
    Zhang Z; Jia JP; Zhang YJ; Liu G; Zhou F; Zhang BC
    Onco Targets Ther; 2020; 13():7089-7100. PubMed ID: 32801743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA RUSC1-AS1 contributes to the progression of hepatocellular carcinoma cells by modulating miR-340-5p/CREB1 axis.
    Liu C; Tang L; Xu M; Lin Y; Shen J; Zhou L; Ho L; Lu J; Ai X
    Am J Transl Res; 2021; 13(3):1022-1036. PubMed ID: 33841637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA TP73-AS1 Promotes Cell Proliferation and Inhibits Cell Apoptosis in Clear Cell Renal Cell Carcinoma Through Repressing KISS1 Expression and Inactivation of PI3K/Akt/mTOR Signaling Pathway.
    Liu G; Zhao X; Zhou J; Cheng X; Ye Z; Ji Z
    Cell Physiol Biochem; 2018; 48(1):371-384. PubMed ID: 30016766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of long non-coding RNA DBH-AS1 inhibits osteosarcoma progression by PI3K-AKT signaling pathways and indicates good prognosis.
    Liu ZB; Wang JA; Lv RQ
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1418-1427. PubMed ID: 30840262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA ADAMTS9-AS1 knockdown suppresses cell proliferation and migration in glioma through downregulating Wnt/β-catenin signaling pathway.
    Zhou C; Zhao H; Wang S; Dong C; Yang F; Zhang J
    Bosn J Basic Med Sci; 2022 Jun; 22(3):395-402. PubMed ID: 34923953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway.
    Shi H; Pu J; Zhou XL; Ning YY; Bai C
    Tumour Biol; 2017 May; 39(5):1010428317697568. PubMed ID: 28459375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xihuang pills induce apoptosis in hepatocellular carcinoma by suppressing phosphoinositide 3-kinase/protein kinase-B/mechanistic target of rapamycin pathway.
    Teng YJ; Deng Z; Ouyang ZG; Zhou Q; Mei S; Fan XX; Wu YR; Long HP; Fang LY; Yin DL; Zhang BY; Guo YM; Zhu WH; Huang Z; Zheng P; Ning DM; Tian XF
    World J Gastrointest Oncol; 2022 Apr; 14(4):872-886. PubMed ID: 35582102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway.
    Zhang Z; Zhu J; Huang Y; Li W; Cheng H
    Diagn Pathol; 2018 Nov; 13(1):85. PubMed ID: 30390677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long Non-Coding RNA TTN-AS1 Promotes the Proliferation and Invasion of Colorectal Cancer Cells by Activating miR-497-Mediated PI3K/Akt/mTOR Signaling.
    Cui Z; Han B; Wang X; Li Z; Wang J; Lv Y
    Onco Targets Ther; 2019; 12():11531-11539. PubMed ID: 31920341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of lncRNA Fez family zinc finger protein 1 antisense RNA1 in hepatocellular carcinoma].
    Yao J; Wang XP; Zhang ZZ; Yang J; Yang Z; Qian HX
    Zhonghua Zhong Liu Za Zhi; 2019 Sep; 41(9):667-674. PubMed ID: 31550856
    [No Abstract]   [Full Text] [Related]  

  • 16. lncRNA TM4SF1-AS1 Activates the PI3K/AKT Signaling Pathway and Promotes the Migration and Invasion of Lung Cancer Cells.
    Zhou F; Wang J; Chi X; Zhou X; Wang Z
    Cancer Manag Res; 2020; 12():5527-5536. PubMed ID: 32765064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. lncRNA CADM1-AS1 inhibits cell-cycle progression and invasion via PTEN/AKT/GSK-3β axis in hepatocellular carcinoma.
    Wang F; Qi X; Li Z; Jin S; Xie Y; Zhong H
    Cancer Manag Res; 2019; 11():3813-3828. PubMed ID: 31118799
    [No Abstract]   [Full Text] [Related]  

  • 18. Alpha1-ACT Functions as a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway via Activation of PTEN.
    Zhu H; Liu Q; Tang J; Xie Y; Xu X; Huang R; Zhang Y; Jin K; Sun B
    Cell Physiol Biochem; 2017; 41(6):2289-2306. PubMed ID: 28456796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RHPN1-AS1 Drives the Progression of Hepatocellular Carcinoma via Regulating miR-596/IGF2BP2 Axis.
    Fen H; Hongmin Z; Wei W; Chao Y; Yang Y; Bei L; Zhihua S
    Curr Pharm Des; 2020; 25(43):4630-4640. PubMed ID: 31692433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA ABHD11-AS1 predicts the prognosis of pancreatic cancer patients and serves as a promoter by activating the PI3K-AKT pathway.
    Qiao X; Lv SX; Qiao Y; Li QP; Ye B; Wang CC; Miao L
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8630-8639. PubMed ID: 30575903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.